1 Min Read
COPENHAGEN, May 29 (Reuters) - Novo Nordisk:
* Novo Nordisk submits application in the US for including data from the DEVOTE trial in the Tresiba label
* Click here, to read more: (Reporting by Copenhagen Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.